Skip to content

A Study on the Effectiveness of Mingyueguang Optimized Lenses in Myopia Control for Children and Adolescents

A Study on the Effectiveness of Mingyueguang Optimized Lenses in Myopia Control for Children and Adolescents

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121735
Enrollment
Unknown
Registered
2026-04-02
Start date
2025-08-27
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Control Group:Single vision lenses (Mingyue Lens Co., Ltd.)
Experimental Group:Optically optimized lenses (Mingyue Lens Co., Ltd.)

Sponsors

Henan Provincial Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Aged 8 to 14 years (inclusive of 8 and 14 years old), gender unrestricted. 2. Meet the diagnostic criteria for simple myopia, with a spherical equivalent refraction between -0.75 D and -6.00 D (inclusive), and astigmatism = 1.0 in both eyes. 4. Intraocular pressure (IOP) < 21 mmHg in both eyes. 5. Willing to participate in the trial for one year without wearing other types of lenses. 6. Understand the trial objectives and voluntarily agree to participate by signing the informed consent form (For minors under 18 years of age, consent must be obtained from both the participant and their guardian, with corresponding signatures on the informed consent form).

Exclusion criteria

Exclusion criteria: 1. Patients who use contact lenses. 2. Patients with a history of myopia control treatment within the past 3 months or those planning to undergo such treatment during the clinical study period. 3. Patients with any known active ocular disease and/or infection. 4. Patients with amblyopia in either eye or any other known binocular vision disorder, such as accommodative insufficiency. 5. Patients with a history of systemic diseases that cause immunodeficiency (e.g., acute or chronic sinusitis, diabetes, Down syndrome, rheumatoid arthritis, psychiatric disorders, or any other condition deemed by the investigator as unsuitable for wearing spectacles). 6. Patients who have undergone strabismus surgery, refractive surgery, or intraocular surgery. 7. Patients who have previously participated in other drug or medical device clinical trials and have not reached the study endpoint within one month prior to screening. 8. Patients unable to comply with the scheduled follow-up visits. 9. Patients considered by the investigator to be unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Axial Length ;Adverse event;

Secondary

MeasureTime frame
Uncorrected Visual Acuity (UVA) ; Best-Corrected Visual Acuity (BCVA) ;Cycloplegic Objective Refraction (including refractive error) Cycloplegic;Corneal Curvature / Keratometry ;Evaluation of wearing comfort;

Countries

China

Contacts

Public ContactTianbin Lyu

Henan Provincial Eye Hospital (Affiliated to Henan Provincial People‘s Hospital)

tbinl67@163.com+86 187 3719 5779

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026